PTGX - Protagonist Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$115.40
DETAILS
HIGH:
$121.00
LOW:
$108.00
MEDIAN:
$117.00
CONSENSUS:
$115.40
UPSIDE:
16.34%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 46.0 | 434.4 | 60 | 26.6 | 27.4 | 28.6 | 0.2 | 30.9 | 20.1 | 0 | 0 | 0 |
| Cost of Revenue | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.2 | 0 |
| Gross Profit | 44.8 | 434.4 | 60 | 26.6 | 27.4 | 28.6 | 0.2 | 30.9 | 20.1 | (0.3) | (0.2) | 0 |
| Operating Expenses | ||||||||||||
| R&D Expenses | 159.3 | 138.1 | 120.2 | 126.2 | 126.0 | 76.0 | 65.0 | 59.5 | 46.2 | 25.7 | 11.8 | 7.5 |
| SG&A Expenses | 44.9 | 43.5 | 33.5 | 31.7 | 27.2 | 18.6 | 15.7 | 13.7 | 11.8 | 7.0 | 3.0 | 1.9 |
| Other Expenses | (1.2) | 0 | 0 | 0 | 0 | (1.5) | (0.0) | 0 | 0 | (0.0) | 0 | 0 |
| Operating Expenses | 202.9 | 181.6 | 153.7 | 158.0 | 153.2 | 93.1 | 80.8 | 73.2 | 58.0 | 32.7 | 14.8 | 9.3 |
| Operating Income | ||||||||||||
| Operating Income | (158.1) | 252.8 | (93.7) | (131.4) | (125.8) | (64.5) | (80.5) | (42.3) | (37.9) | (32.7) | (14.8) | (9.3) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.6 | 0.2 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 28.8 | 26.3 | 14.9 | 4.1 | 0.4 | 0.9 | 2.8 | 2.6 | 0.9 | 0.2 | 0.0 | 0.0 |
| Profitability | ||||||||||||
| EBITDA | (128.1) | 253.7 | (90.3) | (128.0) | (123.1) | (63.6) | (77.0) | (39.2) | (36.6) | (32.3) | (14.5) | (9.1) |
| EBIT | (129.3) | 252.8 | (93.7) | (131.4) | (125.8) | (64.5) | (77.7) | (39.7) | (37.0) | (32.7) | (14.8) | (9.3) |
| Income Before Tax | (129.3) | 279.4 | (79.0) | (127.4) | (125.6) | (64.8) | (77.9) | (39.7) | (37.0) | (37.2) | (14.9) | (11.1) |
| Income Tax Expense | 0.8 | 4.2 | 0 | 0 | 0 | 1.3 | (0.7) | (0.8) | 0 | 0 | 0.1 | 0 |
| Net Income | (130.1) | 275.2 | (79.0) | (127.4) | (125.6) | (66.2) | (77.2) | (38.9) | (37.0) | (37.2) | (14.9) | (11.1) |
| Per Share Data | ||||||||||||
| EPS (Basic) | -2.05 | 4.47 | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
| EPS (Diluted) | -2.05 | 4.23 | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
| Shares Outstanding | 63.6 | 61.6 | 56.8 | 49.0 | 46.3 | 34.4 | 25.9 | 22.4 | 17.7 | 6.5 | 5.9 | 5.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 128.4 | 97.2 | 186.7 | 125.7 | 123.7 | 117.4 | 33.0 | 82.2 | 106.0 | 21.1 |
| Short-Term Investments | 439.0 | 321.7 | 154.9 | 111.6 | 203.2 | 188.5 | 100.0 | 46.6 | 38.0 | 56.5 |
| Net Receivables | 4.5 | 168.5 | 10.3 | 0.1 | 5.3 | 3.8 | 6.8 | 4.6 | 1.8 | 2.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.1 | (8.7) | (7.7) |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.8 | (0.2) | 10.2 | 8.2 |
| Total Current Assets | 577.6 | 591.6 | 355.6 | 243.1 | 340.7 | 315.6 | 145.3 | 137.5 | 150.9 | 83.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 11.7 | 12.6 | 2.1 | 4.6 | 6.7 | 6.4 | 7.7 | 0.9 | 0.9 | 0.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 78.9 | 140.3 | 0 | 0 | 0 | 2 | 0 | 0.5 | 11.5 | 10.2 |
| Other Non-Current Assets | 0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.5 | 0.5 | 0.5 | 0.5 | 0.0 |
| Total Non-Current Assets | 92.3 | 153.1 | 2.4 | 4.9 | 7.0 | 8.9 | 9.6 | 2.0 | 12.8 | 10.7 |
| Total Assets | 669.9 | 744.7 | 358.0 | 247.9 | 347.7 | 324.5 | 154.9 | 139.5 | 163.7 | 94.0 |
| Current Liabilities | ||||||||||
| Account Payables | 5.3 | 1.6 | 0.8 | 3.6 | 1.6 | 3.1 | 2.8 | 5.7 | 1.3 | 1.2 |
| Short-Term Debt | 2.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 9.6 | 18.9 | 0 | 0.1 | 2.5 | 17.2 | 19 | 8.2 | 31.8 | 0 |
| Other Current Liabilities | 15.5 | 23.7 | 6.8 | 5.0 | 7.1 | 6.4 | 4.6 | 9.5 | 6.8 | 0.1 |
| Total Current Liabilities | 45.4 | 47.4 | 21.3 | 31.2 | 44.0 | 40.2 | 35.4 | 26.2 | 42.6 | 6.4 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 9.8 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.7 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 11.7 | (0.2) | 0 | 0 | 0.1 | 0 | 0.8 | 0.5 | 0 |
| Total Non-Current Liabilities | 9.7 | 22.0 | 0 | 1.1 | 3.7 | 4.6 | 39.5 | 0.8 | 0.5 | 0 |
| Total Liabilities | 55.2 | 69.4 | 21.3 | 32.3 | 47.7 | 44.9 | 75.0 | 27.0 | 43.1 | 6.4 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (470.7) | (340.5) | (615.7) | (536.8) | (409.4) | (283.8) | (217.7) | (140.5) | (101.5) | (64.6) |
| Accumulated Other Comprehensive Income | 0.6 | (0.1) | (0.1) | (0.4) | (0.3) | 0.0 | (0.2) | (0.2) | (0.0) | (0.2) |
| Total Stockholders' Equity | 614.7 | 675.3 | 336.7 | 215.6 | 300.0 | 279.6 | 80.0 | (140.5) | (101.5) | (64.6) |
| Total Liabilities & Equity | 669.9 | 744.7 | 358.0 | 247.9 | 347.7 | 324.5 | 154.9 | (113.5) | (58.4) | (58.2) |
| Debt Metrics | ||||||||||
| Total Debt | 10.3 | 10.9 | 1.1 | 3.7 | 5.9 | 6.0 | 17.0 | 0 | 0 | 0 |
| Net Debt | (118.1) | (86.4) | (185.6) | (122.1) | (117.8) | (111.4) | (16.0) | (82.2) | (106.0) | (21.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 0 | 275.2 | (79.0) | (127.4) | (125.6) | (66.2) | (77.2) | (38.9) | (37.0) | (37.2) |
| Depreciation & Amortization | 0 | 2.9 | 3.3 | 3.4 | 2.8 | 2.6 | 2.5 | 0.5 | 0.4 | 0.3 |
| Stock-Based Compensation | 46.0 | 37.6 | 29.3 | 24.2 | 16.4 | 7.9 | 8.4 | 6.9 | 4.2 | 2.1 |
| Change in Working Capital | 146.2 | (122.6) | (19.5) | (7.8) | (3.3) | (19.0) | 26.1 | (18.0) | 35.6 | (0.1) |
| Other Non-Cash Items | (134.5) | (8.9) | (4.4) | (0.5) | 1.8 | 0.8 | (0.6) | 0.2 | 0.6 | 4.7 |
| Operating Cash Flow | 57.7 | 184.2 | (70.2) | (108.1) | (107.9) | (72.5) | (41.5) | (49.9) | 3.9 | (30.0) |
| Investing Activities | ||||||||||
| Capital Expenditure | (1.6) | (1.4) | (0.6) | (0.8) | (1.1) | (0.5) | (1.0) | (0.5) | (0.7) | (0.4) |
| Acquisitions | 0 | 0 | 0 | (91.5) | 14.8 | 90.5 | 52.7 | 0 | 0 | 0.0 |
| Purchases of Investments | (546.6) | (621.7) | (191.0) | (214.9) | (286.6) | (280.0) | (166.9) | (71.1) | (39.5) | (73.2) |
| Sales/Maturities of Investments | 498.8 | 323.6 | 152.4 | 307.1 | 271.8 | 189.5 | 114.2 | 73.8 | 56.0 | 14.2 |
| Other Investing Activities | 0 | 0 | 0 | 91.5 | (14.8) | (90.5) | (52.7) | 2.7 | 16.5 | 0.0 |
| Investing Cash Flow | (49.3) | (299.5) | (39.3) | 91.5 | (15.9) | (91.0) | (53.7) | 2.2 | 15.8 | (59.3) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | (10.5) | 9.8 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.5) | (0.6) | 38.4 | 4.3 | 6.1 | 2.8 | 1.8 | 0.9 | 1.0 | 0.2 |
| Financing Cash Flow | 22.9 | 25.9 | 170.5 | 18.8 | 129.9 | 247.6 | 46.0 | 24.1 | 65.6 | 106.3 |
| Cash Position | ||||||||||
| Net Change in Cash | 31.1 | (89.5) | 61.0 | 2.1 | 6.1 | 84.4 | (49.2) | (23.8) | 85.4 | 17.0 |
| Cash at Beginning | 97.2 | 187.0 | 126.0 | 123.9 | 117.8 | 33.5 | 82.7 | 106.5 | 21.1 | 4.1 |
| Cash at End | 128.4 | 97.5 | 187.0 | 126.0 | 123.9 | 117.8 | 33.5 | 82.7 | 106.5 | 21.1 |
| Free Cash Flow | 56.1 | 182.8 | (70.8) | (108.9) | (109.0) | (73.0) | (42.5) | (50.4) | 3.2 | (30.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 46.0 | 434.4 | 60 | 26.6 | 27.4 | 28.6 | 0.2 | 30.9 | 20.1 | 0 | 0 | 0 |
| Gross Profit | 44.8 | 434.4 | 60 | 26.6 | 27.4 | 28.6 | 0.2 | 30.9 | 20.1 | (0.3) | (0.2) | 0 |
| Operating Income | (158.1) | 252.8 | (93.7) | (131.4) | (125.8) | (64.5) | (80.5) | (42.3) | (37.9) | (32.7) | (14.8) | (9.3) |
| Net Income | (130.1) | 275.2 | (79.0) | (127.4) | (125.6) | (66.2) | (77.2) | (38.9) | (37.0) | (37.2) | (14.9) | (11.1) |
| EPS (Diluted) | -2.05 | 4.23 | -1.39 | -2.52 | -2.65 | -1.92 | -2.98 | -1.74 | -2.09 | -5.72 | -2.52 | -1.88 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 128.4 | 97.2 | 186.7 | 125.7 | 123.7 | 117.4 | 33.0 | 82.2 | 106.0 | 21.1 | ||
| Total Assets | 669.9 | 744.7 | 358.0 | 247.9 | 347.7 | 324.5 | 154.9 | 139.5 | 163.7 | 94.0 | ||
| Total Debt | 10.3 | 10.9 | 1.1 | 3.7 | 5.9 | 6.0 | 17.0 | 0 | 0 | 0 | ||
| Stockholders' Equity | 614.7 | 675.3 | 336.7 | 215.6 | 300.0 | 279.6 | 80.0 | (140.5) | (101.5) | (64.6) | ||
| Cash Flow | ||||||||||||
| Operating Cash Flow | 57.7 | 184.2 | (70.2) | (108.1) | (107.9) | (72.5) | (41.5) | (49.9) | 3.9 | (30.0) | ||
| Capital Expenditure | (1.6) | (1.4) | (0.6) | (0.8) | (1.1) | (0.5) | (1.0) | (0.5) | (0.7) | (0.4) | ||
| Free Cash Flow | 56.1 | 182.8 | (70.8) | (108.9) | (109.0) | (73.0) | (42.5) | (50.4) | 3.2 | (30.4) | ||